相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors
Denarda Dangaj et al.
CANCER CELL (2019)
Loss of enhancer of zeste homologue 2 (EZH2) at tumor invasion front is correlated with higher aggressiveness in colorectal cancer cells
Julian Boehm et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
The Complexity of PRC2 Subcomplexes
Guido van Mierlo et al.
TRENDS IN CELL BIOLOGY (2019)
EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma
Gang Xiao et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
EZH2 Represses the B Cell Transcriptional Program and Regulates Antibody-Secreting Cell Metabolism and Antibody Production
Muyao Guo et al.
JOURNAL OF IMMUNOLOGY (2018)
Genetics of Natural Killer Cells in Human Health, Disease, and Survival
Peter Parham et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 36 (2018)
Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study
Antoine Italiano et al.
LANCET ONCOLOGY (2018)
Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis
Anxo Martinez-Ordonez et al.
ONCOGENE (2018)
Inhibition of Enhancer of zeste homolog 2 (EZH2) induces natural killer cell-mediated eradication of hepatocellular carcinoma cells
Suresh Bugide et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional program
Alison Hirukawa et al.
NATURE COMMUNICATIONS (2018)
Modulation of EZH2 expression in T cells improves efficacy of anti-CTLA-4 therapy
Sangeeta Goswami et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
The Role of CXC Chemokine Receptors 1-4 on Immune Cells in the Tumor Microenvironment
Katharina Helene Susek et al.
FRONTIERS IN IMMUNOLOGY (2018)
Early immune modulation by single-agent trastuzumab as a marker of trastuzumab benefit
Tiziana Triulzi et al.
BRITISH JOURNAL OF CANCER (2018)
Roles of the immune system in cancer: from tumor initiation to metastatic progression
Hugo Gonzalez et al.
GENES & DEVELOPMENT (2018)
Molecular Mechanisms Directing Migration and Retention of Natural Killer Cells in Human Tissues
Roberta Castriconi et al.
FRONTIERS IN IMMUNOLOGY (2018)
Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential
Lu Gan et al.
BIOMARKER RESEARCH (2018)
Epigenetic Mechanisms Dictating Eradication of Cancer by Natural Killer Cells
Suresh Bugide et al.
TRENDS IN CANCER (2018)
CXCL10 alters the tumour immune microenvironment and disease progression in a syngeneic murine model of high-grade serous ovarian cancer
Katrina K. Au et al.
GYNECOLOGIC ONCOLOGY (2017)
The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy
Daniel Zingg et al.
CELL REPORTS (2017)
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nisha Nagarsheth et al.
NATURE REVIEWS IMMUNOLOGY (2017)
An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation
George P. Souroullas et al.
NATURE MEDICINE (2016)
Targeting EZH2 in cancer
Kimberly H. Kim et al.
NATURE MEDICINE (2016)
Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer
Xuejiao Song et al.
SCIENTIFIC REPORTS (2016)
Role of the Polycomb Repressive Complex 2 (PRC2) in Transcriptional Regulation and Cancer
Anne Laugesen et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?
Claudia Cantoni et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
NK cells and cancer: you can teach innate cells new tricks
Maelig G. Morvan et al.
NATURE REVIEWS CANCER (2016)
Ezh2 regulates differentiation and function of natural killer cells through histone methyltransferase activity
Jie Yin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Is all cancer therapy immunotherapy?
Marcia Belvin et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Trastuzumab emtansine (T-DM1) renders HER2+ breast cancer highly susceptible to CTLA-4/PD-1 blockade
Philipp Mueller et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors
Daniel Zingg et al.
NATURE COMMUNICATIONS (2015)
CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo
Erik Wennerberg et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
NK cells exacerbate the pathology of influenza virus infection in mice
Gang Zhou et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma
Valerie Chew et al.
GUT (2012)
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
Michael T. McCabe et al.
NATURE (2012)
EZH2 Depletion Blocks the Proliferation of Colon Cancer Cells
Bettina Fussbroich et al.
PLOS ONE (2011)
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
Ryan D. Morin et al.
NATURE GENETICS (2010)
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
Thomas Ernst et al.
NATURE GENETICS (2010)
Role of the polycomb protein EED in the propagation of repressive histone marks
Raphael Margueron et al.
NATURE (2009)
The trafficking of natural killer cells
Claude Gregoire et al.
IMMUNOLOGICAL REVIEWS (2007)
An elaborate pathway required for Ras-mediated epigenetic silencing
Claude Gazin et al.
NATURE (2007)
Evidence for NK cell subsets based on chemokine receptor expression
Robert D. Berahovich et al.
JOURNAL OF IMMUNOLOGY (2006)
The Polycomb group protein EZH2 directly controls DNA methylation
E Viré et al.
NATURE (2006)
Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells
LP Su et al.
CLINICAL CANCER RESEARCH (2005)
CXCR4 regulates growth of both primary and metastatic breast cancer
MCP Smith et al.
CANCER RESEARCH (2004)
Trafficking of Natural Killer Cells
MA Morris et al.
CURRENT MOLECULAR MEDICINE (2004)
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
CG Kleer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Role of histone H3 lysine 27 methylation in polycomb-group silencing
R Cao et al.
SCIENCE (2002)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
分享论文
